Consensus-based Algorithms to Address Opioid Misuse Behaviors Among Individuals Prescribed Long-term Opioid Therapy
2 other identifiers
interventional
49
1 country
1
Brief Summary
The NIH Helping to End Addiction Long-term (HEAL) initiative has identified a critical next step to addressing the opioid crisis: improving treatments for opioid misuse behaviors (e.g., using more opioids than prescribed, illicit substance use) in patients prescribed long-term opioid therapy for chronic pain. In previous work, the investigators have developed innovative consensus-based algorithms to manage these behaviors. By developing implementation strategies for these algorithms, this project is directly responsive to the HEAL initiative and promises to reduce opioid misuse-related harms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2021
CompletedFirst Posted
Study publicly available on registry
January 10, 2022
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedResults Posted
Study results publicly available
June 18, 2025
CompletedJanuary 8, 2026
December 1, 2025
1.6 years
November 28, 2021
January 16, 2025
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility of Algorithms
The number of algorithms used by physicians was assessed via a survey administered at the end of the 6- or 9-month implementation period, measuring self-reported toolkit utilization during the study. Our primary feasibility benchmark will be that 80% of physicians report using at least one algorithm during the study period.
At the end of the 6- or 9-month implementation period
Acceptability of Algorithms
Acceptability of the algorithms was assessed via a self-report survey administered at the end of the 6- or 9-month implementation period, measuring physicians' awareness of the algorithms and self-reported toolkit use within six months of implementation. Our primary acceptability benchmark is that at least 80% of physicians report awareness of the algorithm implementation and at least 50% report using the algorithms during the study period. Additionally, qualitative interviews with physicians and staff provided further insights, which were analyzed using thematic analysis.
At the end of the 6- or 9-month implementation period
Secondary Outcomes (4)
Preliminary Effectiveness of Algorithms - MME Reduction ≥10%
Pre-implementation (12 months), implementation (6 to 9 months), post-implementation (12 months)
Preliminary Effectiveness - Average MME Within Last 90 Days
Pre-implementation (12 months), implementation (6 or 9 months), post-implementation (12 months)
Preliminary Effectiveness of Algorithms - Opioid Discontinuation
Pre-implementation (12 months), implementation (6 to 9 months), post-implementation (12 months)
Preliminary Effectiveness of the Algorithms - New OUD Diagnoses
Pre-implementation (12 months), implementation (6 to 9 months), post-implementation (12 months)
Study Arms (1)
Implementation Bundle
EXPERIMENTALThe 'Implementation Bundle' was integrated into all three participating clinics over six to nine months.
Interventions
The algorithm implementation package includes a link to the algorithms in the Electronic Health Record, Smartphrases, audited feedback, and instructions.
Eligibility Criteria
You may qualify if:
- Clinicians practicing at UPMC community primary care clinics.
You may not qualify if:
- Clinicians not practicing at UPMC community primary care clinics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15231, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study's findings are limited by its pilot nature, focusing on a small number of clinics and clinicians. Results may not be generalizable to other settings or populations. Additionally, qualitative data were collected from a subset of participants, which may not fully represent all perspectives. The limited follow-up time may also restrict the interpretation of longer-term outcomes or broader feasibility.
Results Point of Contact
- Title
- Dr. Jessica Merlin
- Organization
- University of Pittsburgh
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Merlin
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 28, 2021
First Posted
January 10, 2022
Study Start
March 1, 2022
Primary Completion
September 30, 2023
Study Completion
September 30, 2024
Last Updated
January 8, 2026
Results First Posted
June 18, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share